Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily

Biochemical and Biophysical Research Communications

Volumn 329, Issue 4, 2005, Pages 1275-1281

  Barbosa Sicard, Eduardo ^a   Markovic, Marija ^a,b   Honeck, Horst ^a   Christ, Baghat ^a   Muller, Dominik N ^a,b   Schunck, Wolf Hagen ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CYP2C11; CYP2C23; CYP2C8; CYP2C9; Cytochrome P450; Eicosanoid; Eicosapentaenoic acid; Epoxidation; n 3 polyunsaturated fatty acid

Indexed keywords

17,18 EPOXYEICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 2C23; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; EPOXYGENASE; EPOXYICOSATRIENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARMYWORM; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SUBSTRATE; EPOXIDATION; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HYPOTHESIS; LIPID DIET; METABOLITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY;

INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 17644391400     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.103     Document Type: Article

References (36)

1. A.P. Simopoulos Essential fatty acids in health and chronic disease Am. J. Clin. Nutr. 70 1999 560S 569S
2. W.E. Conner Importance of n-3 fatty acids in health and disease Am. J. Clin. Nutr. 70 2000 171S 175S
3. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
4. D.B. Jump The biochemistry of n-3 polyunsaturated fatty acids J. Biol. Chem. 277 2002 8755 8758
5. S.C. Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clin. Nutr. 79 2004 935 945
6. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res. 41 2000 163 181
7. D.C. Zeldin Epoxygenase pathway of arachidonic acid metabolism J. Biol. Chem. 276 2001 36059 36062
8. J.C. McGiff, and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am. J. Physiol. 277 1999 R607 R623
9. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol. Rev. 82 2001 131 185
10. I. Fleming Cytochrome P450 enzymes in vascular homeostasis Circ. Res. 89 2001 753 762
11. M. Van Rollins, P.D. Frade, and O.A. Carretero Oxidation of 5,8,11,14,17-eicosapentaenoic acid by hepatic and renal microsomes Biochim. Biophys. Acta 966 1988 133 149
12. E.H. Oliw, and H.W. Sprecher Metabolism of polyunsaturated (n-3) fatty acids by monkey seminal vesicles: isolation and biosynthesis of omega-3 epoxides Biochim. Biophys. Acta 1086 1991 287 294
13. J. Theuer, E. Shagdarsuren, D.N. Muller, E. Kaergel, H. Honeck, J.-K. Park, A. Fiebeler, R. Dechend, H. Haller, F.C. Luft, and W.-H. Schunck Inducible iNOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage Kidney Int. 67 2005 1 11
14. H.R. Knapp, A.J. Miller, and J.A. Lawson Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man Prostaglandins 42 1991 47 54
15. Y. Zhang, C.L. Oltman, T. Lu, H.C. Lee, K.C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BK(Ca) channels Am. J. Physiol. Heart Circ. Physiol. 280 2001 H2430 H24340
16. B. Lauterbach, E. Barbosa-Sicard, M.H. Wang, H. Honeck, E. Kaergel, J. Theuer, M.L. Schwartzman, H. Haller, F.C. Luft, M. Gollasch, and W.-H. Schunck Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators Hypertension 39 2002 609 613
17. T. Lu, M. VanRollins, and H.C. Lee Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study Mol. Pharmacol. 62 2002 1076 1083
18. D. Schwarz, P. Kisselev, S.S. Ericksen, G.D. Szklarz, A. Chernogolov, H. Honeck, W.-H. Schunck, and I. Roots Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid Biochem. Pharmacol. 67 2004 1445 1457
19. B.E. Daikh, J.M. Lasker, J.L. Raucy, and D.R. Koop Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9 J. Pharmacol. Exp. Ther. 271 1994 1427 1433
20. D.C. Zeldin, R.N. DuBois, J.R. Falck, and J.H. Capdevila Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform Arch. Biochem. Biophys. 322 1995 76 86
21. S. Imaoka, P.J. Wedlund, H. Ogawa, S. Kimura, F.J. Gonzalez, and H.Y. Kim Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase J. Pharmacol. Exp. Ther. 267 1993 1012 1016
22. V.R. Holla, K. Makita, P.G. Zaphiropoulos, and J.H. Capdevila The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading J. Clin. Invest. 104 1999 751 760
23. D.N. Muller, J. Theuer, E. Shagdarsuren, E. Kaergel, H. Honeck, J.K. Park, M. Markovic, E. Barbosa-Sicard, R. Dechend, M. Wellner, T. Kirsch, A. Fiebeler, M. Rothe, H. Haller, F.C. Luft, and W.H. Schunck A PPARα activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury Am. J. Pathol. 164 2 2004 521 532
24. D. Schwarz, P. Kisselev, I. Cascorbi, W.-H. Schunck, and I. Roots Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants Carcinogenesis 22 2001 453 459
25. J.R. Falck, P. Yadagiri, and J.H. Capdevila Synthesis of epoxyeicosatrienoic acids and heteroatom analogs Methods Enzymol. 187 1990 357 364
26. J.H. Capdevila, S. Wei, C. Helvig, J.R. Falck, J. Belosludtsev, G. Truan, S.E. Graham-Lorence, and J.A. Peterson The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM3 J. Biol. Chem. 271 1996 22663 22671
27. T. Omura, and R. Sato The carbon monoxide-binding pigment of liver microsomes J. Biol. Chem. 239 1964 2370 2378
28. Y. Yasukochi, and B.S. Masters Some properties of detergent-solubilized NADPH-cytochrome c (cytochrome P450) reductase purified by biospecific affinity chromatography J. Biol. Chem. 251 1976 5335 5344
29. L. Hoernsten, J. Bylund, and E.H. Oliw Dexamethasone induces bisallylic hydroxylation of polyunsaturated fatty acids by rat liver microsomes Arch. Biochem. Biophys. 332 1996 261 268
30. E.H. Oliw, S. Okamoto, L. Hornsten, and F. Sato Biosynthesis of prostaglandins from 17(18)epoxyeicosatetraenoic acid, a cytochrome P-450 metabolite of eicosapentaenoic acid Biochim. Biophys. Acta 1126 1992 261 268
31. J.P.F. Chin, and A.M. Dart How do fish oils affect vascular function ? Clin. Exp. Pharm. Physiol. 22 1995 71 81
32. M.Y. Abeywardena, and R.J. Head Longchain n-3 polyunsaturated fatty acids and blood vessel function Cardiovasc. Res. 52 2001 361 371
33. W.B. Campbell, D. Gebremedhin, P.F. Pratt, and D.R. Harder Identification of epoxyeicosatrienoc acids as endothelium-derived hyperpolarizing factors Circ. Res. 78 1996 415 423
34. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
35. I. Fleming Cytochrome P450 epoxygenases as EDHF synthase(s) Pharmacol. Res. 49 2004 525 533
36. D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee, and M. VanRollins Cytochrome P-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels J. Pharmacol. Exp. Ther. 303 2002 768 776